Zuberitamab (HS006) 是一种靶向CD20的单克隆抗体,可用于癌症,包括弥漫性大 B 细胞淋巴瘤研究。
生物活性 | Zuberitamab (HS006) is a monoclonal antibody that targetsCD20and can be used incancerresearch, including diffuse large B-cell lymphoma[1]. |
体内研究 (In Vivo) | Zuberitamab (0.1 mg/kg, intravenous injection, on day 0 and 10, 2 weeks) alone has no or minimal effect on tumor growth, when combined with BR105 results in significant inhibition of tumor growth with good anti-tumor efficacy in IRPα-humanized B-NDG mice tumor xenograft model[1].
|
CAS 号 | |
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |